View Older Stories View More Recent Stories

Mar 6, 2014 10:34AM Notable Analyst Rating Changes 03/06: (BIIB) (COG) (HA) Upgraded; (AUXL) (LOV) (ARTC) Downgraded

Mar 6, 2014 09:51AM Buy Canadian Solar (CSIQ) on Weakness; FY14 Outlook Reinforces Strength - Roth

Mar 6, 2014 08:30AM GSV Capital Corp. to Present at the 26th Annual ROTH Conference on March 10, 2014

Mar 6, 2014 08:11AM Roth Capital Starts Durata Therapeutics (DRTX) at Buy

Mar 5, 2014 04:05PM Vical to Present at the ROTH Capital Partners 26th Annual Growth Stock Conference

Mar 5, 2014 10:50AM Notable Analyst Rating Changes 03/05: (P) (TRMB) (DST) Upgraded; (DDS) (SPLS) (PEI) Downgraded

Mar 5, 2014 09:32AM Pre-Open Stock Movers 3/5: (FCEL) (ARWR) (SWHC) Higher; (XOMA) (HCI) (CSIQ) Lower (more...)

Mar 5, 2014 09:02AM ANI Pharma (ANIP) Prices 1.4M Common Stock Offering at $31/Share

Mar 5, 2014 08:45AM Arno Therapeutics to Present at 26th Annual ROTH Conference

Mar 5, 2014 07:50AM Roth Restarts Cytokinetics (CYTK) at Buy; Get in Now Ahead of April '14 ALS Data

Mar 5, 2014 07:20AM Roth Capital Re-Initiated Cytokinetics (CYTK) at Buy

Mar 4, 2014 06:04PM After Hours Stock Movers 3/4: (BV) (SWHC) (AVAV) Higher; (XOMA) (CHEF) (THOR) Lower (more...)

Mar 4, 2014 04:51PM ANI Pharma (ANIP) Plans Common Stock Offering

Mar 4, 2014 11:17AM Reis, Inc. to Present to Investors at Roth Capital Partners 26th Annual Conference

Mar 4, 2014 09:26AM JinkoSolar (JKS) Issues Confident Q4 Beat, FY14 Outlook is Strong; Roth Keeps at 'Buy'

Mar 4, 2014 09:08AM Near-Term Volatility Expected on Exec Shift, But Fundamentals Inact for Synta Pharma (SNTA) - Roth

Mar 4, 2014 09:04AM BioLineRx (BLRX) Prices 8.4M Offering at $2.50/ADS

Mar 4, 2014 08:35AM OvaScience (OVAS) Prices 5M Offering at $10/Share

Mar 4, 2014 08:26AM Investors Probably Already Looking Past SolarCity (SCTY) Accounting Snafu - Roth

Mar 4, 2014 07:10AM Roth Capital Starts Constant Contact (CTCT) at Buy

Mar 4, 2014 07:00AM Quadrant 4 Systems to Present at Roth Capital Partners 26th Annual Conference

Mar 3, 2014 05:55PM BioLineRx (BLRX) Lower on Stock Offering

Mar 3, 2014 04:01PM RGS Energy to Present at the 26th Annual ROTH Conference on March 10, 2014

Mar 3, 2014 01:58PM Dendreon (DNDN) Makes Progress in FY13, But Road Ahead Still Bumpy - Roth

Feb 28, 2014 12:19PM Roth Still Positive on Ligand (LGND) Following Promacta sNDA Submission

Feb 28, 2014 08:43AM Pedevco (PED) to Offer Common Stock

Feb 28, 2014 08:41AM Neptune Technologies (NEPT) Prices 10M Shares at $2.50

Feb 28, 2014 07:00AM Broadwind Energy to Present at the 26th Annual Roth Conference

Feb 27, 2014 05:00PM Neptune Tech (NEPT) Commences Common Stock Offering

Feb 27, 2014 01:00PM Landec to Present at the 26th Annual ROTH Conference on March 12, 2014

Feb 26, 2014 09:00AM I.D. Systems to Present at 26th Annual ROTH Conference on March 11, 2014

Feb 26, 2014 08:30AM Black Diamond to Present at the 26th Annual ROTH Conference on March 11, 2014

Feb 25, 2014 04:05PM Speed Commerce to Present at the 26th Annual ROTH Conference on March 11, 2014

Feb 25, 2014 09:01AM SolarCity (SCTY) Q1 Outlook Constrained, But FY14 Deployment Outlook Kept in Check - Roth

Feb 25, 2014 08:30AM Edgewater to Present at the 26th Annual ROTH Conference on March 12, 2014

Feb 24, 2014 02:15PM Pharmacyclics' (PCYC) IMBRUVICA Drives Strong Q4 Results; Roth Boosts PT to $183

Feb 24, 2014 02:10PM Pharmacyclics (PCYC) PT Raised to $183 at Roth Capital

Feb 24, 2014 11:33AM Roth Reaffirms Curis (CRIS) at Buy; Erivedge, Internal Pipeline Both Ongoing Strengths

Feb 24, 2014 09:33AM Several Themes in Focus for SolarCity's (SCTY) Q4 Report; Upside Surprises Unlikely - Roth

Feb 24, 2014 09:00AM ZAGG Inc to Present at 26th Annual Roth Conference

Feb 20, 2014 07:04AM Roth Capital Downgrades Hecla Mining (HL) to Neutral

Feb 20, 2014 07:00AM Curis Reports Fourth Quarter and Year-End 2013 Financial Results

Feb 19, 2014 09:36AM Roth Eases Estimates on Enphase (ENPH) Following Q4 Results; Maintains 'Buy' Rating

Feb 19, 2014 08:22AM Roth Capital Downgrades Silvercrest Mines (SVLC) to Neutral

Feb 13, 2014 01:48PM Roth Lifts PT on Retrophin (RTRX) to $51; Impressive Manchester Pharma Purchase Will Bolster Business Plan

Feb 13, 2014 10:55AM Concert Pharmaceuticals (CNCE) IPO Jumps Higher

Feb 13, 2014 10:49AM Notable Analyst Rating Changes 02/13: (ANR) (ATHN) (NSPH) Upgraded; (DEPO) (REGN) (AEM) Downgraded

Feb 13, 2014 07:52AM Roth Capital Boosts PT on Pharmacyclics (PCYC) to $166; Strong IMBRUVICA Sales Ramp Expected

Feb 13, 2014 07:46AM Roth Capital Downgrades DepoMed Inc (DEPO) to Neutral

Feb 13, 2014 07:45AM Roth Capital Upgrades Nanosphere (NSPH) to Buy

View More Recent Stories View Older Stories